{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:50:17Z","timestamp":1765702217973,"version":"3.48.0"},"reference-count":44,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"unspecified","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Health Care Region Kronoberg, Sweden","award":["Grant nr 781451 and 781121"],"award-info":[{"award-number":["Grant nr 781451 and 781121"]}]},{"name":"Research Council of Southeastern Sweden","award":["Grant nr 860391 and 969506"],"award-info":[{"award-number":["Grant nr 860391 and 969506"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,7,2]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe the prevalence of cardiovascular disease (CVD) at the time of diagnosis of adult-onset type 1 (T1D) and type 2 (T2D) diabetes, in a recent cohort and compare to a previous cohort from the same region. Further, to explore factors influencing the prevalence of pre-existing CVD, including age, sex, body mass index (BMI) and C-peptide; in the later cohort also heart failure, hyperlipidaemia, tobacco use and physical activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Two prospective cross-sectional cohort studies compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>All primary health care centres and hospitals in Kalmar and Kronoberg counties in Southeastern Sweden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults with newly diagnosed T1D or T2D (classified by combination of islet antibodies and C-peptide) in 1998\u20132001 and 2016\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Prevalence of hypertension and CVD at diagnosis of diabetes, and associations with beta-cell function, in two cohorts collected 15 years apart. Further, to explore factors influencing the prevalence of hypertension and CVD, and level of C-peptide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In patients with newly diagnosed T2D, mean age-at-onset had decreased (66\u00b114.1 years vs 63\u00b112.6, p\u22640.001) and mean BMI had increased (29.0\u00b15.4 vs 31.4\u00b15.8\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , p\u22640.001). Prevalence of pre-existing myocardial infarction had decreased in both T1D (18% vs 7%, p=0.03) and T2D (25% vs 11%, p\u22640.001). Pre-existing hypertension had increased in both T1D (23% vs 40%, p=0.01) and T2D (44% vs 61%, p\u22640.001). C-peptide level was lower and was associated with several cardiovascular conditions in newly diagnosed T2D in 2016\u20132017 (p=0.048\u2009p\u22640.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with newly diagnosed T2D were younger, with higher BMI, compared with 15 years earlier, a challenge for diabetes care. Prevalence of pre-existing myocardial infarction had decreased notably, in line with, but still less than in the general population; while pre-existing hypertension had increased, in both diabetes types. C-peptide was associated with several cardiovascular conditions in newly diagnosed T2D in the recent cohort, which warrants further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-095630","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T09:11:05Z","timestamp":1752657065000},"page":"e095630","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular disease and beta-cell function at diagnosis of serologically defined adult-onset type 1 and type 2 diabetes in two Swedish cohorts 15 years apart"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3385-4777","authenticated-orcid":false,"given":"Viveca","family":"Ritsinger","sequence":"first","affiliation":[{"name":"Division of Cardiology, Karolinska Institute Department of Medicine Solna, Stockholm, Stockholm County, Sweden"},{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecka","family":"Gunnarsson","sequence":"additional","affiliation":[{"name":"Medical Faculty; Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Melin","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"},{"name":"Institution of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6749-2829","authenticated-orcid":false,"given":"Magnus","family":"Hillman","sequence":"additional","affiliation":[{"name":"Institution of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Stogianni","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"},{"name":"Department of Endocrinology, Karolinska University Hospital, Huddinge, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-6103","authenticated-orcid":false,"given":"Sara","family":"Holmberg","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"},{"name":"Department of Medicine and Optometry, Linnaeus University, Kalmar-V\u00e4xj\u00f6, V\u00e4xj\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Johansson","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Sofie","family":"Nilsson Neumark","sequence":"additional","affiliation":[{"name":"Primary Care, Region Kalmar, Kalmar, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert","family":"Krol","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kalmar Hospital, Kalmar, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"R\u00f6\u00f6st","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"},{"name":"Department of Clinical Sciences, Lund University, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Landin-Olsson","sequence":"additional","affiliation":[{"name":"Institution of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Neumark","sequence":"additional","affiliation":[{"name":"Primary Care, Region Kalmar, Kalmar, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-6800","authenticated-orcid":false,"given":"P\u00e4r","family":"Wanby","sequence":"additional","affiliation":[{"name":"Department of Medicine and Optometry, Linnaeus University, Kalmar-V\u00e4xj\u00f6, V\u00e4xj\u00f6, Sweden"},{"name":"Department of Internal Medicine, Kalmar Hospital, Kalmar, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Thunander","sequence":"additional","affiliation":[{"name":"Department of Research and Development, Region Kronoberg, V\u00e4xj\u00f6, Sweden"},{"name":"Institution of Clinical Sciences, Endocrinology and Diabetes, Lund University, Lund, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025121400472556000_15.7.e095630.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09089-X"},{"key":"2025121400472556000_15.7.e095630.2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114551746"},{"key":"2025121400472556000_15.7.e095630.3","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afh026"},{"key":"2025121400472556000_15.7.e095630.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00440.x"},{"key":"2025121400472556000_15.7.e095630.5","unstructured":"International Diabetes Federation . IDF Diabetes Atlas Tenth edition. Brussels: International Diabetes Federation 2021, 2021. Available: https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/ [Accessed 13 Oct 2024]."},{"key":"2025121400472556000_15.7.e095630.6","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1007\/s00125-020-05277-3","article-title":"Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden","volume":"63","author":"Andersson","year":"2020","journal-title":"Diabetologia"},{"key":"2025121400472556000_15.7.e095630.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.07.022"},{"key":"2025121400472556000_15.7.e095630.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0770"},{"key":"2025121400472556000_15.7.e095630.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408214"},{"key":"2025121400472556000_15.7.e095630.10","doi-asserted-by":"crossref","first-page":"107943","DOI":"10.1016\/j.diabres.2019.107943","article-title":"Standard mortality rates and years of life lost for serologically defined adult-onset type 1 and type 2 diabetes - A fifteen year follow-up","volume":"160","author":"Thunander","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2025121400472556000_15.7.e095630.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62154-6"},{"key":"2025121400472556000_15.7.e095630.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01858.x"},{"key":"2025121400472556000_15.7.e095630.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1608664"},{"key":"2025121400472556000_15.7.e095630.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2025121400472556000_15.7.e095630.15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0797"},{"key":"2025121400472556000_15.7.e095630.16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00592-015-0835-8","article-title":"Incidence of type 1 diabetes in age groups above 15 years: facts, hypothesis and prospects for future epidemiologic research","volume":"53","author":"Bruno","year":"2016","journal-title":"Acta Diabetol"},{"key":"2025121400472556000_15.7.e095630.17","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"2025121400472556000_15.7.e095630.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-022-01184-3","article-title":"Depression was associated with younger age, female sex, obesity, smoking, and physical inactivity, in 1027 patients with newly diagnosed type 2 diabetes: a Swedish multicentre cross-sectional study","volume":"22","author":"Melin","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"2025121400472556000_15.7.e095630.19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00592-023-02096-x","article-title":"A comparison in women with newly diagnosed diabetes between those with and without a history of gestational diabetes: a new perspective","volume":"60","author":"Stogianni","year":"2023","journal-title":"Acta Diabetol"},{"key":"2025121400472556000_15.7.e095630.20","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0749"},{"key":"2025121400472556000_15.7.e095630.21","doi-asserted-by":"publisher","DOI":"10.1080\/00365510050216411"},{"key":"2025121400472556000_15.7.e095630.22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00125-022-05857-5","article-title":"Cardiovascular outcomes in type 1 and type 2 diabetes","volume":"66","author":"Rosengren","year":"2023","journal-title":"Diabetologia"},{"key":"2025121400472556000_15.7.e095630.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198711263172206"},{"key":"2025121400472556000_15.7.e095630.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz388"},{"key":"2025121400472556000_15.7.e095630.25","unstructured":"The Swedish National Diabetes Register (NDR) . Annual Report 2023 [Internet]. Gothenburg: The Swedish National Diabetes Register 2023, 2023. Available: https:\/\/ndr.registercentrum.se\/ [Accessed 13 Oct 2024]."},{"key":"2025121400472556000_15.7.e095630.26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121400472556000_15.7.e095630.27","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.9.1522"},{"key":"2025121400472556000_15.7.e095630.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0655-7"},{"key":"2025121400472556000_15.7.e095630.29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1133"},{"key":"2025121400472556000_15.7.e095630.30","unstructured":"The National Board of Health and Welfare . Myocardial infarctions in sweden 1994-2014. The National Board of Health and Welfare; 2015. Available: https:\/\/www.socialstyrelsen.se\/globalassets\/sharepoint-dokument\/artikelkatalog\/statistik\/2015-11-1.pdf [Accessed 13 Oct 2024]."},{"key":"2025121400472556000_15.7.e095630.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052187"},{"key":"2025121400472556000_15.7.e095630.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069770","article-title":"Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study","volume":"13","author":"Leosdottir","year":"2023","journal-title":"BMJ Open"},{"key":"2025121400472556000_15.7.e095630.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806359"},{"key":"2025121400472556000_15.7.e095630.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4065-6"},{"key":"2025121400472556000_15.7.e095630.35","unstructured":"Statistics Sweden less-smokers-more snuff users, Available: https:\/\/www.scb.se\/hitta-statistik\/artiklar\/2018\/farre-roker-fler-snusar\/ [Accessed 13 Oct 2024]."},{"key":"2025121400472556000_15.7.e095630.36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2022.100342","article-title":"Ten things to know about ten cardiovascular disease risk factors - 2022","volume":"10","author":"Bays","year":"2022","journal-title":"Am J Prev Cardiol"},{"key":"2025121400472556000_15.7.e095630.37","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.5.968"},{"key":"2025121400472556000_15.7.e095630.38","doi-asserted-by":"publisher","DOI":"10.1177\/2048872614523349"},{"key":"2025121400472556000_15.7.e095630.39","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/eurheartj\/ehad079","article-title":"Revisiting the obesity paradox in heart failure: what is the best anthropometric index to gauge obesity?","volume":"44","author":"Sato","year":"2023","journal-title":"Eur Heart J"},{"key":"2025121400472556000_15.7.e095630.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67663-5"},{"key":"2025121400472556000_15.7.e095630.41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.diabet.2019.04.004","article-title":"Association of C-peptide with diabetic vascular complications in type 2 diabetes","volume":"46","author":"Wang","year":"2020","journal-title":"Diabetes Metab"},{"key":"2025121400472556000_15.7.e095630.42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/1479164117710446","article-title":"C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease","volume":"14","author":"Cardellini","year":"2017","journal-title":"Diab Vasc Dis Res"},{"key":"2025121400472556000_15.7.e095630.43","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"2025121400472556000_15.7.e095630.44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.diabres.2019.03.014","article-title":"C-peptide predicts all-cause and cardiovascular death in a cohort of individuals with newly diagnosed type 2 diabetes. The Skaraborg diabetes register","volume":"150","author":"Pikkemaat","year":"2019","journal-title":"Diabetes Res Clin Pract"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-095630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:47:35Z","timestamp":1765702055000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-095630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjopen-2024-095630"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-095630","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}